The main mission of this initiative is to represent the voice of the global HD community and provide HD community experience to regulators, industry, researchers and governing bodies.

HD-CAB is an instrument to facilitate patient-oriented research and clinical trials as well as fair processes to make treatment accessible for all patients. We will provide the unique expertise of living with HD to stakeholders relevant for therapeutic development.